Buys
Open market- Shares
- Avg price
- Total value
Carl Dambkowski - Chief Medical Officer at Apogee Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- APGE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Carl Dambkowski in Apogee Therapeutics, Inc.
Sells
Open market- Shares
- -113,120
- Avg price
- $90.68
- Total value
- -$10,257,230
Net
Past year- Shares
- -113,120
- Share %
- -100%
- Total value
- -$10,257,230
Reported holdings for Carl Dambkowski in Apogee Therapeutics, Inc.
Form 4 holding
Chief Medical Officer
Apogee Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 168,498
- Estimated value
- $22,607,376
- Report date
- 05 Aug 2026
- Price
- $134.17
- Ownership
- Direct
Form 4 holding
Chief Medical Officer
Apogee Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 110,665
- Estimated value
- Report date
- 05 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Carl Dambkowski in Apogee Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.